Good Biotech; Bad Biotech

12Jun4:15 pmEST

Stock Market Recap 06/12/15 {Video}

If you enjoy my blog posts and videos, then I would encourage you to please click here for more details about joining Market Chess Subscription Services for plenty of value-additive features at a reasonable price. Enjoy the video, and have a great weekend!

12Jun2:46 pmEST

The Essence of a Choppy Market

The daily chart, below, of HACK cybersecurity play, CYBR, is a good example of the type of action to expect in this sideways, choppy market until we see directional resolution. Earlier this morning for members , we looked at initial signs of the stock finding support at the lower light blue support trendline. This came after the stock looked...

12Jun12:36 pmEST

Drugs: Got Anything Good in There or What?

Within the biotechnology sector, the action is becoming even more selective. While the likes of TSRO and AGIO, seen first below on the weekly timeframe, are suffering heavy selling, my BPMC long is being permitted to attempt the highlight ascending triangle daily chart breakout, second below. Regarding AGIO, that weekly chart shows a potential...

12Jun10:39 amEST

Waiting for Twitter's Ship to Come In

It seems a little too neat and clean for TWTR to bottom on the news which many investors had been hoping to hear for a long time, regarding a CEO change. As I noted in my video last night, and at various points since the stock's recent earnings plunge, the $36 level remains one of the last major lines of defense if TWTR is to avoid another...

11Jun5:04 pmEST

Stock Market Recap 06/11/15 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services . In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

11Jun3:18 pmEST

An Important Test of Balance

I posted the following monthly chart of Yahoo! on Stocktwits earlier today, but it is worth another look in the final hour of trading today. YHOO does not report again until late-July. And, as you can plainly see, the stock had broken out from ten-year resistance only to "check-back" to the $40 now for a huge retest. I am looking to see if...

11Jun12:02 pmEST

It's Good to Digest This Gas

After selling the remainder of my UGAZ (triple-bullish ETF for natural gas) long yesterday, in front of this morning's inventory report for the commodity, I am perfectly fine with allowing natty to digest its recent gains. The pertinent issue, of course, is whether natty does, in fact, set up again, or instead gives up the ghost of this week's...

11Jun10:20 amEST

New Age Mobileye Going for the Old Fashioned Breakout

MBLY has been a perennial long watchlist idea inside Market Chess Subscription Services for a while now, with the Israeli self-driving tech firm finally trying to clear and hold over the $48.80 area this morning. On the daily chart, below, the light blue lines denote the sideways channel which has encompassed the consolidation in recent...

10Jun5:07 pmEST

Stock Market Recap 06/10/15 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services . In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

10Jun3:07 pmEST

Good Biotech; Bad Biotech

Into the final hour of trading, Gilead continues to lead the major, large market capitalization biotechnology issues. For a while now GILD and REGN have been the large cap biotech leaders, while AMGN BIIB CELG were churning. After REGN's gap down today, GILD continues to push on higher, oblivious to any weakness around it. That said, GILD is...